Bioventix Plc Holding(s) in Company
April 03 2017 - 6:14AM
UK Regulatory
TIDMBVXP
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer Bioventix
of existing shares to which voting rights are (Sedol
attached: ii B4QVDF0)
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights X
An acquisition or disposal of qualifying financial instruments which may result
in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to
qualifying financial instruments
An event changing the breakdown of voting rights
Other (please
specify):
3. Full name of person(s) subject to the CASTLEFIELD FUND PARTNERS LIMITED
notification obligation: iii
4. Full name of shareholder(s)
(if different from 3.):iv
5. Date of the transaction and date on 27th March 2017
which the threshold is crossed or
reached: v
6. Date on which issuer notified:
3rd April 2017
7. Threshold(s) that is/are crossed or 6%
reached: vi, vii
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of Situation previous Resulting situation after the triggering transaction
shares to the triggering
transaction
if possible
using Number Number Number Number of voting % of voting rights x
the ISIN CODE of of of shares rights
Shares Voting
Rights Direct Direct xi Indirect Direct Indirect
xii
300,000 300,000 320,000 320,000 6.276%
GB00B4QVDF07
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date xiii Conversion Period xiv rights that may be rights
acquired if the
instrument is
exercised/ converted.
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial Exercise Expiration Exercise/ Number of voting rights % of voting rights
instrument price date xvii Conversion instrument refers to xix, xx
period xviii
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
300,000 6.276%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease
to hold:
12. Date on which proxy holder will cease to hold
voting rights:
13. Additional information: Percentage based on Issued Share Capital of
5,098,656
14. Contact name: Richard Vickers
15. Contact telephone number: 0161 233 4890
END
(END) Dow Jones Newswires
April 03, 2017 07:14 ET (11:14 GMT)
Bioventix (LSE:BVXP)
Historical Stock Chart
From Apr 2024 to May 2024
Bioventix (LSE:BVXP)
Historical Stock Chart
From May 2023 to May 2024